Issuu on Google+

Report: Parkinson's Disease - Pipeline Review, H1 2014 Category: Healthcare

Insert Image Height - 3.60 Width – 4.98

Report: Parkinson's Disease - Pipeline Review, H1 2014 Report Coverage

• A snapshot of the global therapeutic landscape of Parkinson's Disease • Review of key pipeline products under drug profile section

• Review of key players involved in the therapeutics development for Parkinson's Disease enlisting all their major and minor projects • Summary of all the dormant and discontinued pipeline projects • Review of the Parkinson's Disease products under development by companies and universities or research institutes based on information derived from company and industry-specific sources

Report: Parkinson's Disease - Pipeline Review, H1 2014 Report Coverage (Continued)

• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages • Detailed assessment of monotherapy and combination therapy

pipeline projects • Coverage of the Parkinson's Disease pipeline on the basis of target, MoA, route of administration and molecule type • Latest news and deals relating related to pipeline products

Report: Parkinson's Disease - Pipeline Review, H1 2014 Report Benefits

• Strategically significant competitor information, analysis, and insights assist to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio

and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Parkinson's Disease • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Report: Parkinson's Disease - Pipeline Review, H1 2014 Report Benefits (Continued)

• Devise corrective measures for pipeline projects by understanding Parkinson's Disease pipeline depth and focus of Indication therapeutics

• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Report: Parkinson's Disease - Pipeline Review, H1 2014 Table of Contents

• Introduction • Parkinson's Disease Overview • Therapeutics Development

• Drug Profiles • Appendix

Report: Parkinson's Disease - Pipeline Review, H1 2014 Report Details

• • • • • • • • •

Publish date: Feb 28, 2014 Number of slides: 775 Geographic coverage: Global Available format: PDF, CD, Hardcopy Price for Single User License: USD 2,500 Price for Site License: USD 5,000 Price for Global User License: USD 7,500 Delivery Time: Within 1 business day Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal

Interested in this report? To view more details regarding this premium market research report, Please click here

For further information, get in touch with us: E-mail: Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports Industry Segments Automotive & Transport

Consumer goods


Food and Beverage

Energy and Utilities

Public Sector

Manufacturing & Construction


Media & Entertainment

IT, Telecom & Electronics



Parkinsons disease review unveil that key players are focusing on therapeutics development